Financials Mentice AB

Equities

MNTC

SE0012673291

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 08:59:57 03/05/2024 pm IST 5-day change 1st Jan Change
31.7 SEK -13.39% Intraday chart for Mentice AB -12.19% -33.54%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,775 2,065 2,442 966.5 1,220 810.5 - -
Enterprise Value (EV) 1 1,742 2,028 2,444 935.9 1,170 726.2 704.1 647.4
P/E ratio -70 x -155 x -83.6 x -31 x -434 x 40.6 x 19.7 x 12.7 x
Yield - - - - - - - -
Capitalization / Revenue 11.9 x 15 x 13.2 x 4.43 x 4.46 x 2.42 x 1.97 x 1.64 x
EV / Revenue 11.7 x 14.7 x 13.2 x 4.29 x 4.28 x 2.17 x 1.71 x 1.31 x
EV / EBITDA -135 x -495 x 978 x -240 x 48.4 x 14 x 8.98 x 6.02 x
EV / FCF - 390 x -78.8 x 505 x 39.6 x 24.6 x 21.6 x 11.6 x
FCF Yield - 0.26% -1.27% 0.2% 2.52% 4.06% 4.64% 8.62%
Price to Book 14.1 x 12.6 x 17.8 x 5.94 x 7.67 x 4.47 x 3.65 x 2.87 x
Nbr of stocks (in thousands) 24,147 24,728 24,769 25,569 25,569 25,569 - -
Reference price 2 73.50 83.50 98.60 37.80 47.70 31.70 31.70 31.70
Announcement Date 27/02/20 04/02/21 03/02/22 03/02/23 15/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 149.4 137.5 185.1 218 273.6 335.4 412.1 494.7
EBITDA 1 -12.9 -4.1 2.5 -3.9 24.2 51.75 78.38 107.5
EBIT 1 -24.48 -18.21 -19.72 -23.95 -0.679 24.85 50.25 77.93
Operating Margin -16.38% -13.25% -10.65% -10.99% -0.25% 7.41% 12.2% 15.75%
Earnings before Tax (EBT) 1 -26.24 -18.59 -21.27 -24.04 -0.013 24.96 50.4 78.46
Net income 1 -20.6 -13.1 -29.2 -30.66 -2.817 20.25 40.94 63.45
Net margin -13.79% -9.53% -15.78% -14.07% -1.03% 6.04% 9.93% 12.82%
EPS 2 -1.050 -0.5400 -1.180 -1.220 -0.1100 0.7803 1.607 2.492
Free Cash Flow 1 - 5.196 -31.03 1.854 29.53 29.5 32.67 55.8
FCF margin - 3.78% -16.76% 0.85% 10.79% 8.79% 7.93% 11.28%
FCF Conversion (EBITDA) - - - - 122.02% 57% 41.68% 51.89%
FCF Conversion (Net income) - - - - - 145.67% 79.8% 87.95%
Dividend per Share 2 - - - - - - - -
Announcement Date 27/02/20 04/02/21 03/02/22 03/02/23 15/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 67.7 53.08 45.11 51.1 68.66 64.96 74.31 63.9 70.43 45.34 82.75 81.25 91.65
EBITDA 1 12 -1.3 -12.2 -1.9 11.5 7.3 10.7 4 2.3 -18.4 10.9 10.96 20.49
EBIT 1 4.019 -6.082 -17.22 -7.255 6.602 0.103 4.822 -2.043 -3.561 -24.2 4.148 4.213 13.24
Operating Margin 5.94% -11.46% -38.17% -14.2% 9.62% 0.16% 6.49% -3.2% -5.06% -53.36% 5.01% 5.19% 14.45%
Earnings before Tax (EBT) 1 3.075 -6.935 -16.75 -7.37 7.018 -0.632 4.771 -1.696 -2.455 -23.99 6.474 6.624 12.69
Net income 1 -4.2 -7.425 -17.64 -7.746 2.143 -1.483 1.473 0.016 -2.823 -24.64 3.525 3.583 10.45
Net margin -6.2% -13.99% -39.1% -15.16% 3.12% -2.28% 1.98% 0.03% -4.01% -54.34% 4.26% 4.41% 11.4%
EPS 2 -0.1700 -0.3000 -0.7100 -0.3000 0.0800 -0.0600 0.0600 - -0.1100 -0.9600 0.1975 0.2021 0.3871
Dividend per Share - - - - - - - - - - - - -
Announcement Date 03/02/22 27/04/22 21/07/22 26/10/22 03/02/23 27/04/23 20/07/23 26/10/23 15/02/24 03/05/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 2.01 - - - - -
Net Cash position 1 32.6 37.2 - 30.6 49.6 84.3 106 163
Leverage (Debt/EBITDA) - - 0.8028 x - - - - -
Free Cash Flow 1 - 5.2 -31 1.85 29.5 29.5 32.7 55.8
ROE (net income / shareholders' equity) - -9.09% -19.5% -20.5% -1.75% 12% 20.6% 25.1%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 5.200 6.600 5.530 6.360 6.220 7.080 8.690 11.00
Cash Flow per Share - - - - - - - -
Capex 1 - 25.3 25.9 13.1 6.99 14.9 17.3 19.3
Capex / Sales - 18.43% 13.99% 5.99% 2.55% 4.44% 4.2% 3.89%
Announcement Date 27/02/20 04/02/21 03/02/22 03/02/23 15/02/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
31.7 SEK
Average target price
55.33 SEK
Spread / Average Target
+74.55%
Consensus